Experimental drug reverses severe fatty liver disease by repairing the gut

ScienceDaily reports that an experimental drug called DT-109 has reversed severe fatty liver disease in animal studies. The drug works by repairing the gut barrier and preventing toxins from damaging the liver. This discovery could open the door to new treatments for metabolic-associated fatty liver disease—MASH for short—and potentially other diseases connected to gut health.

Listen to this story

Hear this and more stories in a personalized audio briefing.

Open The Chonkerton